Curate Biosciences Overview
- Year Founded
-
2002
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$3.6M
- Investors
-
10
Curate Biosciences General Information
Description
Operator of a life science company intended to develop cell processing technologies and reduce the total vein-to-vein cost. The company's cell processing system allows a faster path to a cleaner and a larger quantity of starting cells, that gently isolate leukocytes using the fastest microfluidic technology, enabling healthcare professionals to obtain a larger quantity of healthier leukocytes compared to other separation technologies.
Contact Information
Website
www.curatebio.comCorporate Office
- 2715 Loker Avenue West
- Carlsbad, CA 92010
- United States
Corporate Office
- 2715 Loker Avenue West
- Carlsbad, CA 92010
- United States
Curate Biosciences Timeline
Curate Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 20. Grant | 31-Jan-2023 | $3.6M | Completed | Generating Revenue | ||
| 19. Debt - General | 31-Dec-2022 | Completed | Generating Revenue | |||
| 18. Later Stage VC (Series C2) | 31-Aug-2022 | Completed | Generating Revenue | |||
| 17. Grant | 19-Jul-2022 | Completed | Generating Revenue | |||
| 16. Later Stage VC (Series C2) | 16-Apr-2021 | Completed | Generating Revenue | |||
| 15. Later Stage VC (Series C1) | 19-Mar-2020 | Completed | Generating Revenue | |||
| 14. Early Stage VC (Series B) | 31-Jan-2020 | Completed | Generating Revenue | |||
| 13. Grant | 17-Apr-2018 | Completed | Pre-Clinical Trials | |||
| 12. Grant | 01-Apr-2018 | $2.3M | $11.8M | Completed | Pre-Clinical Trials | |
| 11. Accelerator/Incubator | $11.8M | Completed | Pre-Clinical Trials |
Curate Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C2 | ||||||||
| Series C1 | ||||||||
| Series B | ||||||||
| Series A1 | 289,340 | $0.000010 | 8% | $7 | $7 | 1x | $7 | 2.93% |
| Series A | 1,883,654 | $0.000010 | 8% | $4 | $4 | 1x | $4 | 19.08% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Curate Biosciences Comparisons
Industry
Financing
Details
Curate Biosciences Competitors (5)
One of Curate Biosciences’s 5 competitors is PluriSelect, a Formerly VC-backed company based in Leipzig, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| PluriSelect | Formerly VC-backed | Leipzig, Germany | ||||
| Akadeum Life Sciences | Venture Capital-Backed | Ann Arbor, MI | ||||
| Applied Cells | Venture Capital-Backed | Santa Clara, CA | ||||
| Miltenyi Biotec | Private Debt Financed | Bergisch Gladbach, Germany | ||||
| Fresenius Kabi | Corporation | Bad Homburg, Germany |
Curate Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Curate Biosciences Patents
Curate Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220298476-A1 | Methods for producing cell populations with increased nucleic acid uptake | Pending | 19-Mar-2021 | ||
| CA-3204796-A1 | Systems and methods for particle separation and concentration | Pending | 20-Jan-2021 | ||
| JP-2024506485-A | Systems and methods for particle separation and concentration | Pending | 20-Jan-2021 | ||
| US-20220251560-A1 | Methods for producing cell populations with increased nucleic acid uptake | Inactive | 13-Nov-2020 | ||
| US-20220251507-A1 | Methods for producing cell populations with increased nucleic acid uptake | Inactive | 13-Nov-2020 | C12N15/86 |
Curate Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Curate Biosciences Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amgen Ventures | Corporate Venture Capital | Minority | ||
| Vensana Capital | Venture Capital | Minority | ||
| Thylacine Capital | Venture Capital | Minority | ||
| Bio, Tech and Beyond | Accelerator/Incubator | |||
| National Cancer Institute | Government |
Curate Biosciences FAQs
-
When was Curate Biosciences founded?
Curate Biosciences was founded in 2002.
-
Where is Curate Biosciences headquartered?
Curate Biosciences is headquartered in Carlsbad, CA.
-
What is the size of Curate Biosciences?
Curate Biosciences has 25 total employees.
-
What industry is Curate Biosciences in?
Curate Biosciences’s primary industry is Biotechnology.
-
Is Curate Biosciences a private or public company?
Curate Biosciences is a Private company.
-
What is Curate Biosciences’s current revenue?
The current revenue for Curate Biosciences is .
-
How much funding has Curate Biosciences raised over time?
Curate Biosciences has raised $60M.
-
Who are Curate Biosciences’s investors?
Amgen Ventures, Vensana Capital, Thylacine Capital, Bio, Tech and Beyond, and National Cancer Institute are 5 of 10 investors who have invested in Curate Biosciences.
-
Who are Curate Biosciences’s competitors?
PluriSelect, Akadeum Life Sciences, Applied Cells, Miltenyi Biotec, and Fresenius Kabi are competitors of Curate Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
